Ivermectin accelerates autophagic death of glioma cells by inhibiting glycolysis through blocking GLUT4 mediated JAK/STAT signaling pathway activation (2022)

Peer-Reviewed Study · Feng Y; Wang J; Cai B; Bai X; Zhu Y · April 2022

Feng Y et al., 2022-04: Glioma study reporting that ivermectin blocks GLUT4-mediated JAK/STAT signalling activation and lowers GLUT4 expression, reducing glycolysis and ATP and accelerating autophagic cell death, with reduced tumour growth in rat xenografts at 10 mg/kg.

Rat models of glioma xenograft were constructed and treated with 10 mg/kg IVM to observe tumor growth and examine the expression levels of GLUT4 and autophagy marker proteins in tumor tissues.

n/a (PubMed abstract)

Feng Y et al., 2022-04: Glioma study reporting that ivermectin blocks GLUT4-mediated JAK/STAT signalling activation and lowers GLUT4 expression, reducing glycolysis and ATP and accelerating autophagic cell death, with reduced tumour growth in rat xenografts at 10 mg/kg. Study type: glioma cell lines (U87) + rat xenograft. N: not stated in the abstract. Country: China (Weinan Central Hospital). Dose: 10 mg/kg in rats (route and schedule not stated in the abstract). Funder/COI: not stated in the record. Comparator: vehicle and AZD-1480 (JAK2 inhibitor) controls. This paper links the autophagy mechanism to mitochondrial/energy metabolism, relevant also to C4. Study type: animal.